A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia

por Kay, Neil E., Strati, Paolo, LaPlant, Betsy R., Leis, Jose F., Nikcevich, Daniel, Call, Timothy G., Pettinger, Adam M., Lesnick, Connie E., Hanson, Curtis A., Shanafelt, Tait D.
Publicado 2016

AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma

por Ailawadhi, Sikander, Parrondo, Ricardo D., Dutta, Navnita, Han, Bing, Ciccio, Gina, Cherukuri, Yesesri, Alegria, Victoria R., LaPlant, Betsy R., Roy, Vivek, Sher, Taimur, Edwards, Brett, Lanier, Stephanie, Manna, Alak, Heslop, Keisha, Caulfield, Thomas, Maldosevic, Emir, Storz, Peter, Manochakian, Rami, Asmann, Yan, Chanan-Khan, Asher A., Paulus, Aneel
Publicado 2023

Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis

por Muchtar, Eli, Gertz, Morie A., LaPlant, Betsy R., Buadi, Francis K., Leung, Nelson, O’Brien, Patrick, Bergsagel, P. Leif, Fonder, Amie, Hwa, Yi Lisa, Hobbs, Miriam, Helgeson, Dania K., Bradt, Erin E., Gonsalves, Wilson, Lacy, Martha Q., Kapoor, Prashant, Siddiqui, Mustaqueem, Larsen, Jeremy T., Warsame, Rahma, Hayman, Suzanne R., Go, Ronald S., Dingli, David, Kourelis, Taxiarchis V., Dispenzieri, Angela, Rajkumar, S. Vincent, Kumar, Shaji K.
Publicado 2022